Icad Share Price Today
(NASDAQ: ICAD)

Name: Icad Share Price Today (NASDAQ: ICAD) - Icad Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Icad share price is $2.25 & ₹195.68 as on 6 Mar 2025, 2.30 'hrs' IST

$2.25

▲

-0.09

(-3.85%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Icad share price in Dollar and Rupees. Guide to invest in Icad stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Icad, along with analyst recommendations, forecasts, and comprehensive financials.

Icad share price movements

Today's Low: $2.21
Today's High: $2.41
$2.25
1.78%
Downside
Day's Volatility :8.28%
Upside
6.62%
52 Weeks Low: $1.18
52 Weeks High: $3.78
$2.25
47.56%
Downside
52 Weeks Volatility :68.78%
Upside
40.48%

Icad (ICAD) Returns

Period	Icad Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	39.29%	2.1%	0.0%
6 Months	54.97%	-4.1%	0.0%
1 Year	19.39%	2.2%	0.0%
3 Years	-43.2%	11.8%	-11.6%

Icad (ICAD) Key Statistics

in dollars & INR

Previous Close	$2.34
Open	$2.36
Today's High	$2.4095
Today's Low	$2.21
Market Capitalization	$62.2M
Today's Volume	$51.4K
52 Week High	$3.78
52 Week Low	$1.18
Revenue TTM	$18.9M
EBITDA	$-5.4M
Earnings Per Share (EPS)	$-0.2
Profit Margin	-14.29%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-17.56%

How to invest in Icad Stock (ICAD) from India?

It is very easy for Indian residents to invest directly in Icad from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Icad stock in both Indian Rupees (INR) and US Dollars (USD). Search for Icad or ICAD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Icad or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Icad shares which would translate to 0.387 fractional shares of Icad as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Icad, in just a few clicks!

Returns in Icad (ICAD) for Indian investors in Rupees

The Icad stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Icad investment value today

Current value as on today

₹1,19,759

Returns

₹19,759

(+19.76%)

Returns from Icad Stock

₹14,796 (+14.8%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Icad (ICAD)

-25%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Icad Stock from India on INDmoney has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Icad

Vanguard Group Inc
4.30%
Arnhold & S. Bleichroeder Advisers, LLC
2.72%
Renaissance Technologies Corp
1.80%
BlackRock Inc
1.34%
Geode Capital Management, LLC
1.05%
Greenwood Capital Associates, LLC
1.03%

Analyst Recommendation on Icad

Buy

88%Buy

11%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Icad(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Icad Stock (ICAD)

What analysts predicted

Upside of 100.0%

Target:

$4.50

Current:

$2.25

Insights on Icad Stock (Ticker Symbol: ICAD)

Price Movement
In the last 1 month, ICAD stock has moved down by -36.6%
Decreasing Revenue
Revenue is down for the last 2 quarters, 5.02M → 4.21M (in $), with an average decrease of 16.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, 1.36M → -1.80M (in $), with an average decrease of 78.5% per quarter
ICAD vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 54.6% return, outperforming this stock by 35.2%
ICAD vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 135.7% return, outperforming this stock by 180.0%
Price to Sales
ForICAD every $1 of sales, investors are willing to pay $3.3, whereas for Boston Scientific Corp., the investors are paying $9.1 for every $1 of sales.

ICAD Icad Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$25.6M	↓ 8.83%
Net Income	$-9.0M	↓ 36.75%
Net Profit Margin	-35.19%	↑ 15.54%

	FY19	Y/Y Change
Revenue	$31.3M	↑ 22.32%
Net Income	$-13.6M	↑ 50.28%
Net Profit Margin	-43.24%	↓ 8.05%

	FY20	Y/Y Change
Revenue	$29.7M	↓ 5.24%
Net Income	$-17.6M	↑ 29.95%
Net Profit Margin	-59.3%	↓ 16.06%

	FY21	Y/Y Change
Revenue	$33.6M	↑ 13.27%
Net Income	$-11.2M	↓ 36.14%
Net Profit Margin	-33.43%	↑ 25.87%

	FY22	Y/Y Change
Revenue	$27.9M	↓ 16.93%
Net Income	$-13.7M	↑ 21.44%
Net Profit Margin	-48.87%	↓ 15.44%

	FY23	Y/Y Change
Revenue	$17.3M	↓ 38.03%
Net Income	$-4.8M	↓ 64.51%
Net Profit Margin	-27.99%	↑ 20.88%

	Q2 FY23	Q/Q Change
Revenue	$5.9M	↑ 1.51%
Net Income	$-1.8M	↓ 53.68%
Net Profit Margin	-29.84%	↑ 35.55%

	Q3 FY23	Q/Q Change
Revenue	$4.1M	↓ 30.55%
Net Income	$-1.4M	↓ 21.49%
Net Profit Margin	-33.73%	↓ 3.89%

	Q4 FY23	Q/Q Change
Revenue	$4.7M	↑ 16.4%
Net Income	$1.4M	↓ 199.13%
Net Profit Margin	28.73%	↑ 62.46%

	Q1 FY24	Q/Q Change
Revenue	$5.0M	↑ 4.49%
Net Income	$-1.2M	↓ 189.72%
Net Profit Margin	-24.67%	↓ 53.4%

	Q2 FY24	Q/Q Change
Revenue	$5.0M	↑ 1.51%
Net Income	$-1.7M	↑ 42.31%
Net Profit Margin	-34.58%	↓ 9.91%

	Q3 FY24	Q/Q Change
Revenue	$4.2M	↓ 16.15%
Net Income	$-1.8M	↑ 3.57%
Net Profit Margin	-42.71%	↓ 8.13%

	FY18	Y/Y Change
Profit	$19.4M	↑ 6.9%

	FY19	Y/Y Change
Profit	$24.2M	↑ 24.69%

	FY20	Y/Y Change
Profit	$21.4M	↓ 11.86%

	FY21	Y/Y Change
Profit	$24.2M	↑ 13.53%

	FY22	Y/Y Change
Profit	$19.8M	↓ 18.28%

	FY23	Y/Y Change
Profit	$14.5M	↓ 26.63%

	Q2 FY23	Q/Q Change
Profit	$4.3M	↑ 5.3%

	Q3 FY23	Q/Q Change
Profit	$3.5M	↓ 19.04%

	Q4 FY23	Q/Q Change
Profit	$4.3M	↑ 20.99%

	Q1 FY24	Q/Q Change
Profit	$4.1M	↓ 4.93%

	Q2 FY24	Q/Q Change
Profit	$4.2M	↑ 4.12%

	Q3 FY24	Q/Q Change
Profit	$3.6M	↓ 13.82%

	FY18	Y/Y Change
Operating Cash Flow	$-3.9M	↓ 47.29%
Investing Cash Flow	$-316.0K	↓ 112.87%
Financing Cash Flow	$7.0M	↑ 22.82%

	FY19	Y/Y Change
Operating Cash Flow	$-7.1M	↑ 83.79%
Investing Cash Flow	$-306.0K	↓ 3.16%
Financing Cash Flow	$10.5M	↑ 51.0%

	FY20	Y/Y Change
Operating Cash Flow	$-7.0M	↓ 1.72%
Investing Cash Flow	$-474.0K	↑ 54.9%
Financing Cash Flow	$19.3M	↑ 83.4%

	FY21	Y/Y Change
Operating Cash Flow	$-9.4M	↑ 34.69%
Investing Cash Flow	$-587.0K	↑ 23.84%
Financing Cash Flow	$17.1M	↓ 11.59%

	FY22	Y/Y Change
Operating Cash Flow	$-12.8M	↑ 35.94%
Investing Cash Flow	$-534.0K	↓ 9.03%
Financing Cash Flow	$355.0K	↓ 97.92%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-405.0K	↓ 73.49%
Investing Cash Flow	$-221.0K	↑ 81.15%
Financing Cash Flow	$46.0K	↓ 388.31%

Icad Technicals Summary

Sell

Neutral

Buy

Icad is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Icad (ICAD) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Icad Inc	-23.53%	54.97%	19.39%	-43.2%	-82.01%
Medtronic Plc	2.26%	4.07%	8.74%	-12.76%	0.68%
Edwards Lifesciences Corp.	0.07%	8.12%	-19.19%	-34.12%	12.08%
Boston Scientific Corp.	0.07%	27.33%	53.68%	143.5%	203.93%
Stryker Corporation	-0.63%	8.92%	9.84%	53.87%	125.87%
Abbott Laboratories	7.11%	21.64%	15.28%	15.75%	78.63%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Icad Inc	NA	NA	-0.56	-0.22	-0.18	-0.09	NA	1.12
Medtronic Plc	28.75	28.75	1.87	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	30.5	30.5	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	83.9	83.9	1.85	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.89	50.89	2.85	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Icad Inc	Buy	$62.2M	-82.01%	NA	-14.29%
Medtronic Plc	Buy	$120.9B	0.68%	28.75	12.83%
Edwards Lifesciences Corp.	Buy	$42.0B	12.08%	30.5	76.75%
Boston Scientific Corp.	Buy	$154.8B	203.93%	83.9	11.07%
Stryker Corporation	Buy	$150.7B	125.87%	50.89	13.25%
Abbott Laboratories	Buy	$238.6B	78.63%	18.34	31.95%

About Icad

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

Organization	Icad
Employees	67
CEO	Ms. Dana R. Brown
Industry	Electronic Technology

Management People of Icad

Name	Title
Ms. Dana R. Brown	President, CEO & Executive Chair
Mr. Eric Lonnqvist	Chief Financial Officer
Mr. Jonathan Go	Chief Technology Officer
Ms. Michelle Strong	Chief Operations Officer
Ms. Annette L. Heroux	Vice President of Administration
Brian Testa	Chief People Officer
Mr. Bill Keyes	Senior VP of Global Sales Operations
Mr. Vasu Avadhanula	Chief Product Officer
Mr. Peter Graham	Senior VP of North American Sales

Important FAQs about investing in ICAD Stock from India :

What is Icad share price today?

Icad share price today stands at $2.25, Open: $2.36 ; Previous Close: $2.34 ; High: $2.41 ; Low: $2.21 ; 52 Week High: $3.78 ; 52 Week Low: $1.18.

The stock opens at $2.36, after a previous close of $2.34. The stock reached a daily high of $2.41 and a low of $2.21, with a 52-week high of $3.78 and a 52-week low of $1.18.

Can Indians buy Icad shares?

Yes, Indians can invest in the Icad (ICAD) from India.

With INDmoney, you can buy Icad at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Icad at zero transaction cost.

How can I buy Icad shares from India?

It is very easy to buy Icad from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Icad (ICAD) be purchased?

Yes, you can buy fractional shares of Icad with INDmoney app.

What are the documents required to start investing in Icad stocks?

To start investing in Icad, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.